FOXO Technologies Valuation Multiples

FOXO Technologies is valued at $280K as of November 2026, a 0.0x revenue multiple. In the last fiscal year, FOXO Technologies revenue was $16M and FOXO Technologies EBITDA was ($9M).

FOXO Technologies Overview

About FOXO Technologies

FOXO Technologies Inc is a technology platform company focused on commercializing longevity science through products and services that serve the life insurance industry. The company's epigenetic technology applies AI to DNA methylation to identify molecular biomarkers of human health and aging. The company has two reportable business segments, FOXO Labs and FOXO Life. The Company manages and classifies its business into two reportable business segments: Healthcare; and Labs and Life.


Founded

2020

HQ

United States

Employees

168

Financials (Last FY)

Revenue: $16M
EBITDA: ($9M)

EV

$280K

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

FOXO Technologies Financials

FOXO Technologies reported last fiscal year revenue of $16M and negative EBITDA of ($9M).

In the same fiscal year, FOXO Technologies generated $8M in gross profit, ($9M) in EBITDA losses, and had net loss of ($12M).


FOXO Technologies P&L

In the most recent fiscal year, FOXO Technologies reported revenue of $16M and EBITDA of ($9M).

FOXO Technologies is unprofitable as of last fiscal year, with gross margin of 49%, EBITDA margin of (53%), and net margin of (76%).

See analyst estimates for FOXO Technologies
Last FY202320242025202620272028
Revenue$16M$145K$4M$16M
Gross Profit$8M$13K$2M$8M
Gross Margin49%9%39%49%
EBITDA($9M)($24M)($7M)($9M)
EBITDA Margin(53%)(16593%)(180%)(53%)
EBIT Margin(21%)(13963%)(147%)(21%)
Net Profit($12M)($26M)($12M)($12M)
Net Margin(76%)(18205%)(306%)(76%)
Net Debt$11M---

Financial data powered by Morningstar, Inc.

FOXO Technologies Stock Performance

FOXO Technologies has current market cap of $280K, and enterprise value of $280K.

Market Cap Evolution


FOXO Technologies' stock price is $0.17.

FOXO Technologies share price increased by 68.8% in the last 30 days.

FOXO Technologies has an EPS (earnings per share) of $-7.50.

See more trading valuation data for FOXO Technologies
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$280K$280K0.0%68.8%110.5%-$-7.50

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

FOXO Technologies Valuation Multiples

FOXO Technologies trades at 0.0x EV/Revenue multiple, and (0.0x) EV/EBITDA.

See NTM and 2027E valuation multiples for FOXO Technologies

FOXO Technologies Financial Valuation Multiples

As of November 16, 2026, FOXO Technologies has market cap of $280K and EV of $280K.

FOXO Technologies has a P/E ratio of (0.0x).

Last FY202320242025202620272028
EV/Revenue0.0x1.9x0.1x0.0x
EV/EBITDA(0.0x)(0.0x)(0.0x)(0.0x)
EV/EBIT(0.1x)(0.0x)(0.0x)(0.1x)
EV/Gross Profit0.0x21.8x0.2x0.0x
P/E(0.0x)(0.0x)(0.0x)(0.0x)
EV/FCF(0.1x)(0.0x)(0.1x)(0.1x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified FOXO Technologies Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

FOXO Technologies Margins & Growth Rates

In the most recent fiscal year, FOXO Technologies reported gross margin of 49%, EBITDA margin of (53%), and net margin of (76%).

See estimated margins and future growth rates for FOXO Technologies

FOXO Technologies Margins

Last FY20242025202720282029
Gross Margin49%39%49%
EBITDA Margin(53%)(180%)(53%)
EBIT Margin(21%)(147%)(21%)
Net Margin(76%)(306%)(76%)
FCF Margin(25%)(70%)(25%)

FOXO Technologies Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth2689%304%
Gross Profit Growth12084%413%
EBITDA Growth(70%)18%
EBIT Growth(71%)(41%)
Net Profit Growth(53%)0%
FCF Growth(57%)42%

Data powered by FactSet, Inc. and Morningstar, Inc.

FOXO Technologies Operational KPIs

FOXO Technologies' revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.2M for the same period.

Access forward-looking KPIs for FOXO Technologies
Last FY202320242025202620272028
Revenue per Employee$0.1M---
Opex per Employee$0.2M---
R&D Expenses to Revenue1%620%8%1%
Opex to Revenue163%15371%292%163%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

FOXO Technologies Competitors

FOXO Technologies competitors include Allurion, Ludwig Enterprises, Moadata, Telemedycyna Polska, Induct, Monsenso, Aino Health, STE Electricité and Kontigo Care.

Most FOXO Technologies public comparables operate across Insurance Carriers, Health Data & Analytics and HealthTech.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Allurion$15M($28M)1.6x1.7x(0.9x)-
Ludwig Enterprises-($1M)--(2.4x)-
Moadata$17M($8M)2.2x-(4.7x)-
Telemedycyna Polska$1M($324K)1.1x-(4.5x)-
Induct$2M$757K1.9x1.9x3.9x6.8x
Monsenso$1M($438K)2.1x-(6.4x)-
Aino Health$3M($239K)1.5x-(15.9x)-

This data is available for Pro users. Sign up to see all FOXO Technologies competitors and their valuation data.

Start Free Trial

FOXO Technologies VC Funding History

Before going public, FOXO Technologies raised $40M in total equity funding, across 2 rounds.


FOXO Technologies Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
Apr-21Series BBespoke Growth Partners; Centrecourt Asset Management$10M--
Nov-19Series A-$30M--

Acquisitions by FOXO Technologies

FOXO Technologies has acquired 4 companies to date.

Last acquisition by FOXO Technologies was on October 29th 2026. FOXO Technologies acquired Ludwig Enterprises for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by FOXO Technologies

Ludwig Enterprises
Vector BioSource
Myrtle Recovery Centers
Big South Fork Medical Center
Description
Ludwig Enterprises Inc is a publicly traded Medical Technology Holding Company with Precision Genomics, Inc. and MyRNA for Life, Inc. as wholly owned subsidiaries. The company's advancements in medical technology and Artificial Intelligence (AI) have awarded it with cutting-edge genomic tools. These genomic tools have the potential to detect diseases early but also to customize treatments that may improve patient outcomes and, in some cases, even extend life. Ludwig is at the forefront of this new era with their proprietary mRNA genetic technology that has the potential to detect genetic biomarkers for inflammatory-driven diseases, including but not limited to heart disease, diabetes, preeclampsia, and cancer. It manages its business on the basis of one operating and reportable segment.
Vector BioSource is a provider of human biospecimens, biofluids and tissues to biotechnology, pharmaceutical and clinical research organizations. It supplies FFPE blocks, frozen samples, blood products and custom collections compliant with FDA and HIPAA standards from diverse donor populations, supporting drug discovery, diagnostics and biomarker studies worldwide.
Myrtle Recovery Centers is a behavioral health provider offering comprehensive treatment for substance use, mental health, and behavioral disorders. Its facilities deliver compassionate care programs tailored to individual recovery needs.
Big South Fork Medical Center is a Jamestown-headquartered facility providing emergency care, inpatient admissions, radiology imaging, respiratory therapy, and laboratory diagnostics in Tennessee. The 25-bed critical access hospital treats acute injuries, performs EKGs, arterial blood gases, and breathing treatments around the clock. Radiology services include X-rays, CT scans, and ultrasounds analyzed by on-site radiologists. Supporting Fentress County residents, it coordinates transfers to tertiary centers when needed.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
Miami, FL
Madison, WI
Knoxville, TN
Syracuse, NY
Deal Date29 Oct 202619 Mar 202514 Jun 202414 Jun 2024
Valuationundisclosed$7M$500K$20M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all FOXO Technologies acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About FOXO Technologies

When was FOXO Technologies founded?FOXO Technologies was founded in 2020.
Where is FOXO Technologies headquartered?FOXO Technologies is headquartered in United States.
How many employees does FOXO Technologies have?As of today, FOXO Technologies has over 168 employees.
Is FOXO Technologies publicly listed?Yes, FOXO Technologies is a public company listed on OTCM.
What is the stock symbol of FOXO Technologies?FOXO Technologies trades under FOXOD ticker.
When did FOXO Technologies go public?FOXO Technologies went public in 2022.
Who are competitors of FOXO Technologies?FOXO Technologies main competitors include Allurion, Ludwig Enterprises, Moadata, Telemedycyna Polska, Induct, Monsenso, Aino Health, STE Electricité, Kontigo Care.
What is the current market cap of FOXO Technologies?FOXO Technologies' current market cap is $280K.
What is the current revenue of FOXO Technologies?FOXO Technologies' last fiscal year revenue is $16M.
What is the current EV/Revenue multiple of FOXO Technologies?Current revenue multiple of FOXO Technologies is 0.0x.
Is FOXO Technologies profitable?No, FOXO Technologies is not profitable.
How many companies FOXO Technologies has acquired to date?As of November 2026, FOXO Technologies has acquired 4 companies.
What was the largest acquisition by FOXO Technologies?$20M acquisition of Big South Fork Medical Center on 14th June 2024 was the largest M&A FOXO Technologies has done to date.
What companies FOXO Technologies acquired?FOXO Technologies acquired Big South Fork Medical Center, Vector BioSource, Myrtle Recovery Centers, and Ludwig Enterprises.
In how many companies FOXO Technologies has invested to date?FOXO Technologies hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to FOXO Technologies

Lists including FOXO Technologies

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial